Abstract:OBJECTIVE Our previous study highlighted that DEDD (death effector domain DNA-binging protein) could inhibit the growth and metastasis of breast cancer.However,the effect of DEDD on multiple drug resistance is still unkown.In this study,we aimed to explore the effects and meschanisms of DEDD on multiple drug resistance of breast cancer.METHODS Stable knockdown DEDD cells were established by transfecting DEDD shRNA into MCF-7 cells.MTS assay was used to evaluate the cell viability of MCF-7 cells (Wild type/WT,MCF-7 control shRNA and DEDD shRNA) after treated with doxorubicin or paclitaxel for indicated times.Cell apoptosis was measured by flow cytometric analysis after Annexin V/PI double staining.The expressions of BCRP (breast cancer resistance protein) were detected by immunobloting.RESULTS After treatment with doxorubicin,MTS results showed that there were significant differences between the different cells (F=89.49,P＜0.001) or different treatment time (F-50.81,P＜0.001) groups.Tthe IC50 values of doxorubicin in MCF-7 DEDD-shRNA cells were (0.97±0.15) and (0.62±0.09) μmol/L respectively after 24 h or 48 h treatment with doxorubicin,which were significantly higher than that of MCF-7 WT cells [(0.46 ± 0.05) μmol/L,(0.26±0.03) μmol/L] and MCF-7 control shRNA cells [(0.39±0.05) μmol/L,(0.25±0.03) μmol/L,P＜0.001].After treatment with paclitaxel,there were significant differences in IC50 between the different cells (F=15.94,P＜ 0.001) or different treatment time (F=129.70,P＜0.001) groups.The IC50 valus of paclitaxel in MCF-7 DEDD-shRNA cells were (16.74±2.26) and (9.88±1.47) μmol/L respectively after treatment for 24 h or 48 h,which were significantly higher than that of MCF-7 WT cells [(13.39±1.44 μmol/L,(7.69±0.92) μmol/L,P=0.001] and MCF-7 control shRNA cells [(12.58±1.15) μmol/L,(7.17±1.12) μmol/L,P＜0.001].After treatment with doxorubicin,apoptosis assay showed that there were significant differences between the different cells (F=131.46,P＜0.001) or different concentrations (F=160.95,P＜0.001) groups.Under normal culture conditions,the apoptotic rates of MCF-7 cells were as follows:MCF-7 control shRNA cells (14.32 ± 1.47)％,MCF-7 DEDD-shRNA cells (11.58 ± 1.63)％.After treatment of 0.5 μmol/L or 1μmol/L doxorubicin for 24 h,the apoptotic rates of MCF-7 DEDD-shRNA cells were (21.62± 1.97)％ and (24.39 ± 2.36)％,which were significantly lower than that of MCF-7 control shRNA cells (36.26±1.87)％ and (38.23±1.46)％,P＜0.001.Similarly,after treatment of 9.37 μmol/L or 18.74 μmol/L paclitaxel for 24 h,there were significant differences between the different cells (F=124.81,P＜0.001) or different concentrations (F=172.56,P＜0.001) groups.The apoptotic rates of MCF-7 DEDD-shRNA cells were (30.26 ± 1.63)％ and (32.18 ± 2.16)％,which were significantly lower than that of MCF-7 control shRNA cells (53.84 ± 2.17)％,P＜ 0.001.Immunobloting results showed that there were significant differences in BCRP levels after treatment with doxorubicin between the different cells (F=14.67,P＜0.001) or different treatment time (F=6.39,P=0.006) groups.After treatment with 0.5 μmol/L doxorubicin for 24 h,the relative levels of BCRP in three kinds of cells were as follows:MCF-7 WT 0.87 ± 0.04,MCF-7 control shRNA 1.06 ± 0.02 and MCF-7 DEDD-shRNA 5.25 ± 0.18.The levels of BCRP in MCF-7 DEDD-shRNA cells were significantly higher compared with MCF-7 WT and MCF-7 control shRNA cells (P＜0.001).After treatment with 0.5 μmol/L doxorubicin for 48 h,the relative levels of BCRP in three kinds of cells were 1.06±0.01,0.97±0.04 and 2.98±0.13.The levels of BCRP in MCF-7 DEDD-shRNA cells showed a deceasing,but still higher that MCF-7 WT and MCF-7 control shRNA cells (P＜0.001).Similarly,there were significant differences in BCRP levels after treatment with paclitaxel between the different cells (F=7.26,P=0.004) or different treatment time (F=8.32,P=0.002) groups.After treatment of 9.37 μmol/L paclitaxel for 24 h,the relative levels of BCRP in three kinds of cells were 0.81±0.05,2.25±0.10 and 1.78±0.14.The levels of BCRP in MCF-7 control shRNA cells were higher than that of MCF-7 WT and MCF-7 DEDD-shRNA cells (P＜0.001).However,after treatment of 9.37 μmol/L paclitaxel for 48 h,the levels of BCRP in MCF-7 DEDD-shRNA increased continuously,and which were significantly higher than that of MCF-7 WT and MCF-7 control shRNA cells (P＜0.001).CONCLUSIONS In this study,we demonstrate that DEDD knockdown in MCF-7 cells showed characteristic multiple drug resistance to conventional chemotherapy drugs.The increasing of BCRP levels was a potential mechanism of multidrug resistance in DEDD lower expression breast cancer cells.

DEDC, a new flavonoid induces apoptosis via a ROS-dependent mechanism in human neuroblastoma SH-SY5Y cells

Apoptosis induced by a new flavonoid in human hepatoma HepG2 cells involves reactive oxygen species-mediated mitochondrial dysfunction and MAPK activation.

2-(Pro-1-ynyl)-5-(5,6-dihydroxypenta-1,3-diynyl) thiophene induces apoptosis through reactive oxygen species-mediated JNK activation in human colon cancer SW620 cells.

A novel non-aromatic B-ring flavonoid: Isolation, structure elucidation and its induction of apoptosis in human colon HT-29 tumor cell via the reactive oxygen species-mitochondrial dysfunction and MAPK activation

A ROS-mediated Mitochondrial Pathway and Nrf2 Pathway Activation Are Involved in BDE-47 Induced Apoptosis in Neuro-2a Cells.

Deltonin Induces Apoptosis in Mda-Mb-231 Human Breast Cancer Cells Via Reactive Oxygen Species-Mediated Mitochondrial Dysfunction and Erk/Akt Signaling Pathways

Inhibition of DEK Enhances Doxorubicin-Induced Apoptosis and Cell Cycle Arrest in T-Cell Acute Lymphoblastic Leukemia Cells

Deoxyelephantopin Induces Apoptosis and Enhances Chemosensitivity of Colon Cancer Via Mir-205/Bcl2 Axis

Delicaflavone induces ROS-mediated apoptosis and inhibits PI3K/AKT/mTOR and Ras/MEK/Erk signaling pathways in colorectal cancer cells.

Dendritic cell factor 1 inhibits proliferation and migration and induces apoptosis of neuroblastoma cells by inhibiting the ERK signaling pathway

Induction of Apoptosis in Human Leukemic Cell Lines by Diallyl Disulfide via Modulation of EGFR/ERK/PKM2 Signaling Pathways.

Cearoin Induces Autophagy, Erk Activation And Apoptosis Via Ros Generation In Sh-Sy5y Neuroblastoma Cells

Mechanism of Deca-BDE-induced Apoptosis in Neuro-2a Cells:Role of Death-Receptor Pathway and Reactive Oxygen Species-Mediated Mitochondrial Pathway

Deoxyelephantopin from Elephantopus Scaber L. Induces Cell-Cycle Arrest and Apoptosis in the Human Nasopharyngeal Cancer CNE Cells

Delphinidin modulates JAK/STAT3 and MAPKinase signaling to induce apoptosis in HCT116 cells

A Novel Compound Derived from Danshensu Inhibits Apoptosis Via Upregulation of Heme Oxygenase-1 Expression in SH-SY5Y Cells

Nitidine chloride induces apoptosis, cell cycle arrest, and synergistic cytotoxicity with doxorubicin in breast cancer cells

Diethyl Blechnic, a Novel Natural Product Isolated from Salvia miltiorrhiza Bunge, Inhibits Doxorubicin-Induced Apoptosis by Inhibiting ROS and Activating JNK1/2

Diethyl Blechnic, a Novel Natural Product Isolated from Bunge, Inhibits Doxorubicin-Induced Apoptosis by Inhibiting ROS and Activating JNK1/2.

Dauricine Attenuates Oct4/sonic Hedgehog Co-Activated Stemness and Induces Reactive Oxygen Species-Mediated Mitochondrial Apoptosis Via AKT/β-catenin Signaling in Human Neuroblastoma and Glioblastoma Stem-Like Cells

Effects and meschanisms of death effector domain DNA-binging protein on multiple drug resistance of breast cancer